Table II.
Serum miR-193b level | ||||
---|---|---|---|---|
Clinicopathological parameters | Patient number | High | Low | P-value |
Age (years) | ||||
≤64.5 | 23 | 10 | 13 | 0.308 |
>64.5 | 24 | 14 | 10 | |
Gender | ||||
Male | 44 | 24 | 20 | 0.067 |
Female | 3 | 0 | 3 | |
R category | ||||
R0 | 34 | 24 | 10 | <0.001 |
R1/R2 | 13 | 0 | 13 | |
Pathological stage | ||||
ypT stage | ||||
ypT0 | 24 | 21 | 3 | <0.001 |
ypT1/2 | 4 | 0 | 4 | |
ypT3/4 | 19 | 3 | 16 | |
ypN stage | ||||
ypN0 | 33 | 20 | 13 | 0.045 |
ypN1 | 14 | 4 | 10 | |
ypM stage | ||||
ypM0 | 40 | 23 | 17 | 0.035 |
ypM1 | 7 | 1 | 6 | |
ypTNM | ||||
ypCRa | 24 | 21 | 3 | <0.001 |
y-stage I/II | 9 | 1 | 8 | |
y-stage III/IV | 14 | 2 | 12 |
Pathological complete response.